A new study led by Ana Losada, head of the Chromosomal Dynamics Group at Spain’s National Cancer Research Centre (CNIO), identifies...

Larotrectinib led to rapid/durable responses and high disease control rates in children with TRK fusion-position central nervous system...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients...

"In pediatric cancer care, which has an understandable emphasis on cure, advances that have brought families hope can often mean survival...

The FDA granted a rare pediatric disease designation to elraglusib (9-ING-41), a novel GSK-3β inhibitor, as a potential therapeutic...

Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients...

CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a...

Children with a genetic risk of developing myelodysplastic syndromes (MDS) and other hematopoietic malignancies (HM), such as leukemias...

Research at St. Jude recently showed that the drug capmatinib is effective at crossing the blood-brain-barrier, synergizing with...

Childhood cancer survivors are more likely than the general population to develop subsequent leukemia, even 15 years or more after their...